Because mTOR is involved in diverse phenomena, such as autophagy [10], cell proliferation [6], and cell motility [12], its regulation by REDD1 has the potential to be a pharmacological target for various neurological diseases. This evidence concerns the gene MTOR and nervous system disorder.